Chia Tai Enterprises International Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CAIHF research report →
Companywww.ctei.com.hk
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands.
- CEO
- Chawalit Na Muangtoun
- IPO
- 2023
- Employees
- 900
- HQ
- Central, HK
Price Chart
Valuation
- Market Cap
- $217.44M
- P/E
- 8.74
- P/S
- 0.53
- P/B
- 0.92
- EV/EBITDA
- 7.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 15.79%
- Op Margin
- 7.67%
- Net Margin
- 6.39%
- ROE
- 11.11%
- ROIC
- 7.78%
Growth & Income
- Revenue
- $536.71M · 73.69%
- Net Income
- $32.10M · 186.28%
- EPS
- $0.13 · 193.45%
- Op Income
- $38.95M
- FCF YoY
- 4789.84%
Performance & Tape
- 52W High
- $0.28
- 52W Low
- $0.00
- 50D MA
- $0.28
- 200D MA
- $0.28
- Beta
- 3.98
- Avg Volume
- 33.76
Get TickerSpark's AI analysis on CAIHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CAIHF Coverage
We haven't published any research on CAIHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CAIHF Report →